Phase 4 Depression and Anxiety Trial, Recruiting NCT06853431 Sponsor: Second Affiliated Hospital of Wenzhou Medical University Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT06853431
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are generally healthy or have only a mild health condition, as classified by a standard anaesthesia health grading system (known as ASA Grade I or II)
  • Children between 1 and 6 years of age
  • Children who are scheduled to have elective (non-emergency) surgery requiring general anaesthesia
  • Children whose weight is within the normal range for their age
  • Families who have signed the required consent form agreeing to take part

Who may not be able to join:

  • Children whose parent, guardian, or the child themselves does not wish to take part in the study
  • Children who have medical reasons why sedation or anaesthesia would not be safe for them, or who have had an unusual or problem reaction to sedation or anaesthesia in the past
  • Children who are known to have an allergy to the study medicines, opioid medicines, or any of the emergency/rescue medicines used in the trial
  • Children who have a history of heart, brain, liver, kidney, or metabolic (body chemistry) conditions
  • Children who have had an upper respiratory tract infection (such as a cold or similar illness affecting the nose, throat, or airways) within the two weeks before the study
  • Children who have any other health condition that the trial team considers could cause harm to the child during the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Huacheng Liu, Second Affiliated Hospital of Wenzhou Medical University

Phone: 18957755138

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
30 November 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Onset time of sedation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov